US Patent 11920148 Compositions and methods for gene editing
Patent 11920148 was granted and assigned to CRISPR Therapeutics on March, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+30 properties)
Article (+330 characters)
US Patent 11920148 Compositions and methods for gene editing
Article
Patent abstract
The present application provides materials and methods for treating a patient with one or more conditions associated with ANGPTL3 whether ex vivo or in vivo. In addition, the present application provides materials and methods for editing and/or modulating the expression of ANGPTL3 gene in a cell by genome editing.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Ante Sven Lundberg0
Hari Kumar Padmanabhan0
Lawrence Klein0
Samarth Kulkarni0
Yvonne Sarah Aratyn0
Date of Patent
March 5, 2024
0Patent Application Number
164873000
Date Filed
February 21, 2018
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11920148 Compositions and methods for gene editing
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
